Stem Cell Therapy for Diabetic Foot: An Umbrella Review of Systematic Reviews and Meta-Analyses
Advances in Wound Care · 2024
DOI: 10.1089/wound.2023.0136 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Advances in Wound Care, 2024. Verfasst von Hongshuo Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peripheral Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Diabetic Foot, Stem Cell Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Objective
This umbrella review aims to summarize and evaluate the evidence from current systematic reviews/meta-analyses (SRs/MAs) on the effectiveness of stem cell therapy for diabetic foot (DF). Approach: We conducted a comprehensive search in four databases for SRs/MAs that included randomized controlled trials (RCTs) on stem cell therapy for DF. Two separate researchers independently evaluated the methodological quality and evidence quality of the SRs/MAs that were included in the study. We conducted a quantitative synthesis of all RCTs included in the SRs/MAs to obtain objective and updated conclusions. Egger's test and sensitivity analysis are used to examine the reliability of the results.
Results
This umbrella review includes eight SRs/MAs, and their methodological quality and evidence quality were all deemed unsatisfactory. Out of the 8 SRs/MAs, 26 RCTs were included, with a total corrected covered area of 21.4%, indicating a high degree of overlap. The test of super-significance did not yield any significant results. Our updated meta-analysis suggests that DF patients can benefit from stem cell therapy, as indicated by effectiveness in measures, including healing rate, amputation rate, ankle-brachial index, transcutaneous oxygen pressure, ulcer size reduction, complete healing time, pain-free walking distance, rest pain score, and new angiogenesis rate. Innovation: This study conducted a comprehensive evaluation and reanalysis of the current evidence regarding the effectiveness and safety of stem cell therapy for DF, which is the first of its kind.
Conclusion
Based on the existing evidence, stem cell therapy is effective and safe for patients with DF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Peripheral Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Hongshuo Shi
Zitieren
APA
Shi, H., Yuan, X., Fan, W., Yang, X., & Liu, G. (2024). Stem Cell Therapy for Diabetic Foot: An Umbrella Review of Systematic Reviews and Meta-Analyses. Advances in Wound Care. https://doi.org/10.1089/wound.2023.0136
Vancouver
Shi H, Yuan X, Fan W, Yang X, Liu G. Stem Cell Therapy for Diabetic Foot: An Umbrella Review of Systematic Reviews and Meta-Analyses. Advances in Wound Care. 2024. doi:10.1089/wound.2023.0136
BibTeX
@article{Shi2024,
author = {Shi, Hongshuo and Yuan, Xin and Fan, Weijing and Yang, Xiao and Liu, Guobin},
title = {Stem Cell Therapy for Diabetic Foot: An Umbrella Review of Systematic Reviews and Meta-Analyses},
journal = {Advances in Wound Care},
year = {2024},
doi = {10.1089/wound.2023.0136}
}
EUVIMED